Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rASNase vs Oncaspar in Adult ALL
NCT01251809Phase 2Terminated
- Sponsor
- medac GmbH
- Start
- Jan 2011
- Primary completion
- Oct 2012
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by medac GmbH. Started Jan 2011; status: terminated.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01251809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01251809.